Collaboration Deals in Biotechnology 2019-2023


Collaboration Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2023

Publication date
September 2023
Number of pages
Product type
Research report
Available formats
PDF document
Report edition
4 - fully revised and updated

Collaboration Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter collaboration deals.

Fully revised and updated, the report provides details of collaboration deals from 2019 to 2023.

The report provides access to collaboration deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred – contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of collaboration deals announced since 2019 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual collaboration contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of collaboration dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in collaboration as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of collaboration deals.

Chapter 4 provides a review of the leading collaboration deals since 2019. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active collaboration dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of collaboration deals organized by company A-Z, therapy, technology and industry type signed and announced since 2019 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the collaboration deal.

The deal directory includes a comprehensive listing of all collaboration deals announced since 2019. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in collaboration dealmaking since 2019.

In conclusion, this report provides everything a prospective dealmaker needs to know about collaboration alliances.


Key benefits

Collaboration Deals in Biotechnology provides the reader with the following key benefits:

  • Understand deal trends since 2019
  • Browse collaboration deals
  • Benchmark analysis – identify market value of transactions
  • Financials terms - upfront, milestone, royalties
  • Directory of deals by company A-Z, therapy focus and technology type
  • Leading deals by value
  • Most active dealmakers
  • Identify assets and deal terms for each transaction
  • Access contract documents - insights into deal structures
  • Due diligence - assess suitability of your proposed deal terms for partner companies
  • Save hundreds of hours of research time


Report scope

Collaboration Deals in Biotechnology is intended to provide the reader with an in-depth understanding of the collaboration trends and structure of deals entered into by leading biopharma companies worldwide.

Collaboration Deals in Biotechnology includes:

  • Trends in collaboration dealmaking in the biotechnology industry
  • Overview of collaboration deal structure
  • Directory of collaboration deal records covering biotechnology and biotechnology
  • The leading collaboration deals by value
  • Most active collaboration dealmakers
  • The leading collaboration partnering resources


In Collaboration Deals in Biotechnology, the available deals are listed by:

  • Company A-Z
  • Headline value
  • Therapeutic area
  • Technology type


Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.

Collaboration Deals in Biotechnology provides comprehensive access to available records for collaboration deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

  • What are the rights granted or optioned?
  • What rights are granted by the agreement?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are intellectual property rights handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What subcollaboration and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Collaboration Deals in Biotechnology provides the reader with the following key benefits:

  • Understand deal trends since 2019
  • Browse biotechnology collaboration deals
  • Benchmark analysis – identify market value of transactions
  • Financials terms - upfront, milestone, royalties
  • Directory of deals by company A-Z, therapy focus and technology type
  • Leading deals by value
  • Most active dealmakers
  • Identify assets and deal terms for each transaction
  • Access contract documents - insights into deal structures
  • Due diligence - assess suitability of your proposed deal terms for partner companies
  • Save hundreds of hours of research time

Executive Summary


Chapter 1 – Introduction


Chapter 2 – Trends in collaboration dealmaking

2.1. Introduction

2.2. Definition of collaboration deal

2.3. Trends in collaboration deals since 2019

2.3.1. Collaboration dealmaking by year, 2019-2023

2.3.2. Collaboration dealmaking by phase of development, 2019-2023

2.3.3. Collaboration dealmaking by industry sector, 2019-2023

2.3.4. Collaboration dealmaking by therapy area, 2019-2023

2.3.5. Collaboration dealmaking by technology type, 2019-2023

2.3.6. Collaboration dealmaking by most active company, 2019-2023

2.4. Reasons for entering into collaboration partnering deals

2.5. The future of collaboration deals


Chapter 3 – Overview of collaboration deal structure

3.1. Introduction

3.2. Collaboration agreement structure


Chapter 4 – Leading collaboration deals

4.1. Introduction

4.2. Top collaboration deals by value


Chapter 5 – Top 25 most active collaboration dealmakers

5.1. Introduction

5.2. Top 25 most active collaboration dealmakers


Chapter 6 – Collaboration deals including contracts directory

6.1. Introduction

6.2. Collaboration deals with contracts 2019-2023


Deal directory

Deal directory – collaboration dealmaking by companies A-Z

Deal directory – collaboration dealmaking by therapy area

Deal directory – collaboration dealmaking by technology type


About Wildwood Ventures

Current Partnering

Current Agreements

Recent report titles from Current Partnering



Figure 1: Definition of collaboration deal

Figure 2: Trends in collaboration deal announcements, 2019-2023

Figure 3: Collaboration deals signed at each phase of development, 2019-2023

Figure 4: Collaboration deals by industry sector, 2019-2023

Figure 5: Collaboration deals by therapy area, 2019-2023

Figure 6: Collaboration deals by technology type, 2019-2023

Figure 7: Top 25 most active collaboration dealmakers, 2019-2023

Figure 8: Top collaboration deals by value, 2019-2023

Figure 9: Most active collaboration dealmakers, 2019-2023

Pricing options

  • $3,995: single-user (encrypted file - one user/device)
  • $5,995: multi-user (encrypted file - up to 5 users/devices)
  • $9,995: company (unencrypted file)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.


Our guarantee


Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.


Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)


Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.


Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by Evalon.


Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.


Total Trust

Current Partnering is part of Wildwood Ventures Ltd., based in York, United Kingdom. We have been trading successfully online since 2009 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

1ST Biotherapeutics, 2bPrecise, 2cureX, 3B Pharmaceuticals, 3D Medicines, 3SBio, 3T Biosciences, 3Z, 4baseCare, 4C Biomed, 4D Molecular Therapeutics, 9 Meters Biopharma, 10X Genomics, 23andMe, 111, A*STAR Agency for Science, Technology and Research, A*STAR Singapore Immunology Network, A*STAR’ Institute of Molecular and Cell Biology, A2 Biotherapeutics, AavantiBio, AAVnerGene, AB2 Bio, Abbvie, Abcam, AbCellera Biologics, AbCheck, Abdul Latif Jameel Health, Abeona Therapeutics, Abera Bioscience, Abilita Bio, Abintus Bio, ABL Bio, Ablexis, Ab Magnitude Ventures, Abound Bio, Absolute Antibody, Ab Studio, AbTis, Abu Dhabi Stem Cells Center, Abveris, Abzena, ACADIA Pharmaceuticals, AC Bioscience, Accelerator for Technological Research in Genomic Therapies, Acceleron Pharma, Acerand Therapeutics, Acerta Pharma, Acer Therapeutics, aCGT Vector, AchilleS Vaccines, Acrobat Genomics, ACROBiosystems, ACT Therapeutics, Adagene, AdAlta, Adamis Pharmaceuticals, Adaptate Biotherapeutics, Adaptimmune, Adaptive Biotechnologies, Adaptive Phage Therapeutics, Adcentrx Therapeutics, ADC Therapeutics, Adicet Bio, Adimab, Aditx Therapeutics, ADL Bionatur Solutions, ADMA Biologics, Adrestia, Advaccine Biotechnology, Advanced BioNutrition, Advaxis, AdventHealth, Aegea Biotechnologies, Aelis Pharma, Aetion, AffaMed Therapeutics, Affilogic, Affimed Therapeutics, Affini-T Therapeutics, Affinia Therapeutics, AffyXell Therapeutics, AgBiome, AGC Biologics, Agenus Bio, AgeX Therapeutics, Agilent Technologies, AgonOx, AgroSource, AHN Autoimmunity Institute, Aichi Medical University, AiCuris, AimedBio, Ajinomoto, Akadeum Life Sciences, Akeso Biopharma, Akili Interactive Labs, AKL Research and Development, Akoya Biosciences, Akshaya Bio, Alamar Biosciences, Albumedix, Alchemab, Alcyone Therapeutics, Aldevron, Alector, Aleta Biotherapeutics, Alexion Pharmaceuticals, Alex’s Lemonade Stand Foundation, Aligos Therapeutics, AlivaMab Discovery Services, ALK-Abello, Alkermes, Allegheny General Hospital, Allelica, Allen Institute for Brain Science, Allergan, Alliance For Clinical Trials In Oncology, Alligator Bioscience, Allogene Therapeutics, Alloplex Biotherapeutics, Alloy Therapeutics, Allscripts, Almirall, Alnylam Pharmaceuticals, Alpha Biopharma, Alphageneron Pharmaceuticals, Alphamab Biopharmaceuticals, Alpine Immune Sciences, Altamira Therapeutics, Altavant Sciences, Alvotech, ALX Oncology, AlzProtect, Amal Therapeutics, Amazon Web Services, Ambiopharm, Ambrx, Ambry Genetics, American BriVision, American College of Cardiology, American Diabetes Association, Amgen, Amicus Therapeutics, Ampio Pharmaceuticals, Amytrx Therapeutics, Anavex Life Sciences, AnchorDx, Andorra Development and Investment, Andrew Alliance, Angers University, AnGes MG, AnHeart Therapeutics, Anima Biotech, AnimalBiome, Anixa Biosciences, Ankarys Therapeutics, Anokion, Antengene, Antheia, Antidote Therapeutics, Antikor Biopharma, Antion Biosciences, Apellis Pharmaceuticals, Aplastic Anemia & MDS International Foundation, Apollomics, Apollo Therapeutics, Appia Bio, Applied BioMath, Applied Cells, Applied DNA Sciences, Applied Genetic Technologies, Applied StemCell, APRINOIA Therapeutics, Aptamer Therapeutics, Aqilion, Aragen Bioscience, Aragen Life Sciences, Aravive Biologics, Arbor Biotechnologies, Arbutus, Arcadia Biosciences, Arc Bio, Arctic Vision, Arctoris, Arcturus Therapeutics, Arcus Biosciences, Ardena, Arecor, Arena Pharmaceuticals, Ares Genetics, argenx, Argobio, Ariana Pharma, Arista Cereal Technologies, Arnay Sciences, Aro Biotherapeutics, AroCell, Arrakis Therapeutics, Arrowhead Pharmaceuticals, Arsenal Biosciences, Artios Pharma, Artisan Bio, Artiva Biotherapeutics, Artizan Biosciences, Aruvant Sciences, Arvinas, Arzeda, Ascentage Pharma, Ascletis, ASC Therapeutics, Asher Biotherapeutics, Ashvattha Therapeutics, Asieris MediTech, Asklepios Biopharmaceutical, Aslan Pharma, Aspect Biosystems, Assembly Biosciences, Astellas Pharma, Astellas Pharma US, Astero Bio, AstraZeneca, Atalanta Therapeutics, Atara Biotherapeutics, Atavistik Bio, Atea Pharmaceuticals, Athersys, Athos Therapeutics, Atlas Venture, ATMPS, Atomwise, Atreca, ATUM, aTyr Pharma, Audentes Therapeutics, AUM Biosciences, Aurealis Therapeutics, Autigen, Autolus, Avacta, Avalon GloboCare, Avance Biosciences, AvantGen, Avantor, Avatamed, Avectas, Avera Health, Avery Therapeutics, Aviceda Therapeutics, Avidity Biosciences, Avita Therapeutics, Avrobio, Axcelead Drug Discovery Partners, Axcella, Axovant Gene Therapies, B-MoGen Biotechnologies, Bacthera, Barth Syndrome Foundation, Baruch S Blumberg Institute, BASF, Basilea Pharmaceutica, Batavia Biosciences, Baxalta, Baxter International, Bayer, Baylor College of Medicine, Baylor Genetics, Bay State Milling Company, B Braun, BC Cancer Agency, BC Platforms, Beacon Biosignals, Beactica, Beam Therapeutics, BeiGene, Beijing Genomics Institute (BGI), Beijing InnoCare Pharma, Belharra Therapeutics, BenevolentAI, Berg, Berkeley Lights, Beroni Group, Beta Pharma, Be The Match BioTherapies, Beth Israel Deaconess Medical Center, Bethyl Laboratories, Bicycle Therapeutics, BigHat Biosciences, Bill and Melinda Gates Foundation, Bio-Cancer Treatment International, Bio-Me, Bio-Rad Laboratories, Bio-Techne, Bio-Thera Solutions, BioAge Labs, BioArdis, biOasis Technologies, BIOASTER, BioAtla, BioBlast Pharma, BioCanRx, Biocare Medical, BioCentriq, Biocept, Bioceres, BioCopy, BioCure, Biocytogen, Biodesix, Biodextris, BioDuro, Bioforum, Biogen, BioGenetics, Biogenysis, Biognosys, Bioharmony Therapeutics, BioInvent, BioLife Solutions, BioLite Japan, BioLizard, Biolojic Design, BioMap, BioMarin Pharmaceutical, BiomeBank, Biomedical Advanced Research and Development Authority, BioMed X Innovation Center, bioMerieux, Biomica, Biomillenia, BioMotiv, BiomX, Bionaut Labs, BiondVax, Bionetix, BioNTech, BioPharma Plasma, Bio Products Laboratory, Bioqube Ventures, Biorchestra, Biortus Biosciences, Biosceptre International, BioSense Global, Biosion, Biositu Pharmaceutical Technology, BioStrand, Biotem, Biotest, BioTheryX, Biotheus,, BioVaxys, Bioventus, BioVersys, BioXcel, Bioz, Bird Foundation, Bit Bio, BitBiome, BiVictriX Therapeutics, Blanver, Bliss Biopharmaceutical, Bloom Science, Blu Biotech, Bluebird Bio, Bluebridge Technologies, Blueprint Genetics, Blueprint Medicines, BlueRock Therapeutics, Boca Biolistics, Boehringer Ingelheim, Bohai Biomedical, Bolt Biotherapeutics, Bolt Threads, BostonGene, Boston University, Bota Bio, BPL Medical Technologies, BrainXell, BravoVax, Breath Diagnostics, BriaCell Therapeutics, BrickBio, Brickell Biotech, BridgeBio Pharma, Bridge Biotherapeutics, Brigham and Women's Hospital, BrightPath Biotherapeutics, Bright Peak Therapeutics, Brightseed, Brii Biosciences, Bristol-Myers Squibb, Broad Institute, Brown University, Bruker, Bugworks, BullFrog AI, Butantan Institute, Byondis, C2i Genomics, C4 Therapeutics, C4X Discovery, Cabaletta Bio, Cadent, Calico, Calidi Biotherapeutics, California Institute of Technology, Calixar, Calyxt, Cambridge Quantum Computing, CAMP4 Therapeutics, CANbridge Pharmaceuticals, Cancer Research Horizons, Cancer Research UK, Cancer Science Institute of Singapore, CanCure, Candel Therapeutics, Capsida Biotherapeutics, Capsigen, Captivate Bio, Caravan Biologix, Carbiotix, Cardiff University, Cardinal Health, Cargill, Caribou Biosciences, Carina Biotech, Caris Life Sciences, Carisma Therapeutics, Carmine Therapeutics, Carna BioSciences, Carnegie Mellon University, CarThera, Cartherics, CARTI Cancer Center, Casdin Capital, Case Western Reserve University, Casma Therapeutics, Castle Biosciences, Castle Creek Biosciences, Catabasis Pharmaceuticals, Catalent, Catalyst Biosciences, Catholic University Leuven, CDR-Life, Ceapro, Cedars-Sinai Medical Center, Celcuity, Celdara Medical, Celgene, Cell and Gene Therapy Catapult, Cellares, Cellaria Biosciences, Cell Cure Neurosciences, Cellect Biotechnology, Cellectis, Cellectricon, Cellenkos, Cellerys, Cellevolve Bio, CellGenix, Cellibre, CELLINK, Cellistic, Cell Mogrify, CellOrigin Biotech, CellPoint, Cell Signaling Technology, Cell Therapy Manufacturing Center, Cellular Biomedicine, Cellular Origins, Cellworks, Celmatix, Celsius Therapeutics, Celularity, Celyad, Center for Biomarker Research in Medicine, Center for Genomic Regulation, Centessa Pharmaceuticals, Centogene, Centre for Commercialization of Regenerative Medicine (CCRM), Centre Leon Berard, Century Therapeutics, Cepheid, Cerebras Systems, Cerevance, Cerevel Therapeutics, CERo Therapeutics, Certara, Chamishi Therapeutics, Chao Center, Charite Universitatsmedizin Berlin, Chattanooga Center for Neurologic Research, Checkpoint Therapeutics, ChemGenes, Chemveda Life Sciences, Chi-Med, Chiesi Farmaceutici, Children's Hospital Boston, Children's Mercy Hospital, Chime Biologics, China Biotech Services, China Resources Pharmaceutical Commercial Group International Trading, Chinese Academy of Agricultural Science, Chinook Therapeutics, Chiome Bioscience, Cholesgen, Chonnam National University, Chr  Hansen, Chronix Biomedical, Cidara Therapeutics, Cimeio Therapeutics, CIRION BioPharma Research, CJ CheilJedang, CK Life Sciences, Clarity Pharmaceuticals, Clear Creek Bio, Cleveland Clinic, Cleveland University Hospitals, Clinica Universidad Navarra, Clover Biopharmaceuticals, Clover Therapeutics, Clovis Oncology, CMG Pharmaceutical, CM Life Sciences, CMT Research Foundation, CN Bio, Coalition for Epidemic Preparedness Innovations, Coave Therapeutics, Cobra Biologics, Codagenix, Code Biotherapeutics, Codex DNA, Codexis, Codiak BioSciences, Cognate BioServices, CohBar, Colombia Ministry of Health and Social Protection, Colorado Melanoma Foundation, Columbia University, Complix, ConcertAI, Concert Genetics, Confo Therapeutics, ConserV Bioscience, Context Therapeutics, COPD Foundation, Core Biotherapeutics, Cornell University, Corteva Agriscience, CosmosID, Creative Medical Technologies, Crescendo Biologics, Crescendo Bioscience, CRISPR Therapeutics, Cristal Therapeutics, Critical Path Institute (C-Path), Crohn's and Colitis Foundation of America, Crown Bioscience, CSafe Global, CSL Behring, CStone Pharmaceuticals, CTD Holdings, Cue Biopharma, Cullinan MICA, Cullinan Oncology, Culture Biosciences, Cumming, Curacle, Curasan, Curasight, Cure Genetics, CureMatch, Curetis, CureVac, Curia, Curium, Cybrexa Therapeutics, Cyclenium Pharma, Cyclerion Therapeutics, Cyclica, Cyclo Therapeutics, Cyrus Biotechnology, Cystic Fibrosis Foundation, Cytea Bio, Cytecare Cancer Hospitals, Cytiva, CytoLynx Therapeutics, CytoMed Therapeutics, CytomX Therapeutics, Cytoo, CytoSen Therapeutics, Cytovance Biologics, Cytovant Sciences, CYTOVIA Therapeutics, D2M, DAAN Bio Therapeutics, Daewoong Pharmaceutical, Daiichi Sankyo, Dana-Farber Cancer Institute, DanausGT Biotechnology, DarwinHealth, Dassault Systems, DataRobot, Datos Health, Day One Biopharmaceuticals, DCPrime, Debiopharm, Decibel Therapeutics, deCODE Genetics, DeepCDR Biologics, Deep Genomics, Deep Longevity, Deerfield Management, Defence Therapeutics, Defense Advanced Research Projects Agency, Delix Therapeutics, Dementia Discovery Fund, Denali Therapeutics, Denovium, Department of Defense, Dewpoint Therapeutics, Diamyd Medical, Dicerna Pharmaceuticals, DigiLab, DiNAQOR, DIOSynVax, Distributed Bio, Diverse Biotech, DNAnexus, Door Pharmaceuticals, Dorian Therapeutics, DotBio, Dr. Falk Pharma, Dr. Reddy's Laboratories, Dragonfly Therapeutics, Drawbridge Health, Drugs for Neglected Diseases Initiative, DualityBio, Dualogics, Dualsystems Biotech, Duke University, Dunad Therapeutics, DuPont Pharmaceuticals, Dyadic International, DyNAbind, Dynacure, Dynavax Technologies, Dyno Therapeutics, E.T. Horn, Eagle Genomics, Edesa Biotech, EdiGene, Editas Medicine, EditForce, Edith Wolfson Medical Center, Eikonizo Therapeutics, Eikon Therapeutics, Eisai, Elaaj Bio, Elektrofi, Element Biosciences, ElevateBio, Elevation Oncology, Eleven Biotherapeutics, Elicio Therapeutics, Eligo Bioscience, Eli Lilly, Elpiscience, Elsie Biotechnologies, Emendo Biotherapeutics, Emerge Health, Emergence Therapeutics, Emergex Vaccines, Emmaus Life Sciences, Emory University, Empirico, Enamine, Enara Bio, Encoded Therapeutics, EncrypGen, Endevica Bio, Endogena Therapeutics, Endpoint Health, ENDRA Life Sciences, Enesi Pharma, Engitix, Enlivex, Ensoma, Enterome Bioscience, Entos Pharmaceuticals, Entrada Therapeutics, Envisagenics, Enzolytics, Enzyvant Science, EpiAxis Therapeutics, EpimAb Biotherapeutics, Epiphany Dermatology, Epivax, EpiVax Therapeutics, Epizyme, EQRx, Equillium, Eracal Therapeutics, Erasca, Erasmus University Medical Center, ERP Biomarker Qualification Consortium, Ervaxx, Erytech Pharma, Escient Pharmaceuticals, Esperovax, Essex Bio-Technology, eTheRNA immunotherapies, Ethris, Eucure Biopharma, Eureka Eurostars, Eureka Therapeutics, Eurocine Vaccines, Eurofins Discovery, Eutilex, Evaxion Biotech, Evelo Biosciences, Everads Therapy, EverCell Bio, Evercyte, Everest Medicines, Evergreen Theragnostics, EverythingALS Open Innovation Consortium, Evogene, Evolve BioSystems, EvolveImmune Therapeutics, Evommune, EVOQ Therapeutics, Evotec, Evox Therapeutics, Evozyne, EVQLV, Ewha Womans University, Exagen Diagnostics, ExcellaBio, ExCellThera, Exelixis, ExeVir Bio, Exicure, Exonate, Exothera, Expansion Therapeutics, Experimental Therapeutics Centre of Singapore, Expesicor, ExpreS2ion Biotechnologies, Expressive Neuroscience, ExScientia, Exuma Biotech, Exyte, Eyenovia, F-Star Therapeutics, F4 Pharma, Facio Therapies, Facit, Factorial Biotechnologies, FairJourney Biologics, FAR Biotech, Farmacore Biotechnology, Fate Therapeutics, FatiAbGen, Fauna Bio, Federation Bio, Felix Biotechnology, Ferring Pharmaceuticals, Fibrocell Science, FibroGenesis, FineImmune Biotechnology, FivepHusion, Flagship Biosciences, Flagship Pioneering, Flame Biosciences, Flare Therapeutics, Flatiron Health, Florida International University, Flow Pharma, Fluent BioSciences, Fluidigm, FMC, Foghorn Therapeutics, Food and Drug Administration (FDA), Forbius, Forge Therapeutics, Forty Seven, Fosun Kite Biotechnology, Foundation Fighting Blindness, Foundation for the National Institutes of Health (FNIH), Foundation Medicine, Four Points Innovation, FOXO BioScience, FOXO Technologies, Frame Cancer Therapeutics, Francis Crick Institute, Fred Hutchinson Cancer Research Center, FreeMind Group, Freenome, FSD Pharma, FSHD Global Research Foundation, Fujifilm, FUJIFILM Cellular Dynamics, Fujifilm Diosynth Biotechnologies, Fulcrum Therapeutics, Future Fields, G42 Healthcare, Gadeta, Gaia, Galapagos, Galmed Pharmaceuticals, Gamida Cell, Gandeeva Therapeutics, GC Pharma, GE Healthcare, GEMoaB, Gen, Genechem, GeneCode, Genective, GenEdit, GeneDX, Geneious Biologics, Genelux, Genentech, GeneQuantum Healthcare, General Genomics, Generate Biomedicines, Generation Bio, Generation Biotech, Geneseeq, Genesis Therapeutics, GeneThera, Genethon, Genetic Analysis, Genetiks, Genevant Sciences, GenFleet Therapeutics, Genisphere, GenKOre, Genmab, Genocea Biosciences, Genome and Company, Genome Biologics, Genome Institute of Singapore, Genomenon, Genpharm, Gensaic, GenScript Biotech, GenScript ProBio, GentiBio, Genuity Science, Genuv, Genzyme, GeoVax, German Cancer Research Center, Gero, Ghent University, Gibson Oncology, Gicell, Gilead Sciences, Ginkgo BioWorks, Gladstone Institutes, Global Antibiotic Research and Development Partnership, Global Virus Network, GlycoMimetics, Glycostem Therapeutics, Gnubiotics Sciences, Golden Meditech, Goldfinch Bio, GoodRx, Gossamer Bio, GO Therapeutics, Government of Ireland, Government of South Korea, GranBio, Graphite Bio, Graviton Bioscience, Gray Matter, Greenlight Biosciences, Griffith University, Grifols, Gritstone Bio, GSK, GT Apeiron Therapeutics, GT Biopharma, Guangzhou Fanen Biotechnology, Guardant Health, H3 Biomedicine, Hadassah Medical Center, Haihe Laboratory of Cell Ecosystem, Hainan Sinotau Pharmaceutical, HalioDx, Halo Labs, Halozyme Therapeutics, HanAll Pharmaceuticals, Handok Pharmaceuticals, Hangzhou CNK Therapeutics, Hangzhou Zhongmei Huadong Pharmaceutical, Hanmi Pharmaceutical, Hansa Biopharma, Happify Health, Harbour Biomed, Harpoon Therapeutics, Harvard Medical School, Harvard University, HDT Bio, Healion Bio, Healios K.K., Heartseed, Heat Biologics, HebeCell, Hebrew University of Jerusalem, Heidelberg Pharma, Heligenics, Helix, Helomics, Helsinn Therapeutics, Hemanext, HemoShear, Henlius Biotech, HepaTx, Heqet Therapeutics, Hereditary Neuropathy Foundation, Heron Therapeutics, Herophilus, HiberCell, HiFiBio, Hillstream BioPharma, Hitachi, Hitech Health, HitGen, HK inno.N, Hoffmann La Roche, Holobeam Technologies, Holobiome, Hong Kong Baptist University, Horizon Discovery, Horizon Therapeutics, Hospital for Sick Children, Hospital of University of Strasbourg, Hoth Therapeutics, HotSpot Therapeutics, Houston Methodist Research Institute, Huadong Medicine, Hualan Genetic, Hudson-Alpha Institute for Biotechnology, Hudson Institute of Medical Research, Humacyte, Human Cell Atlas, Hummingbird Bioscience, Hutchmed, I-mab, iBio, Icahn School of Medicine at Mount Sinai, iCarbonX, Ichnos Sciences, Ichor Medical Systems, ICL, Idaho Urologic Institute, IDBiologics, IDEAYA Biosciences, iECURE, IFM Therapeutics, IGM Biosciences, Ikarovec, Ikena Oncology, Iksuda Therapeutics, Iktos, iLAC, Ildong Pharmaceutical, Ilias Biologics, Illumina, ImaginAb, Imagine Pharmaceuticals, Imbrium Therapeutics, Imcyse, Imec, Imeka, Immagene, Immatics Biotechnologies, Immix Biopharma, Immodulon Therapeutics, Immorna, Immunai, ImmuNext, ImmunoChina Pharmaceuticals, Immunocore, ImmunoGen, Immunome, Immunomic Therapeutics, ImmunoPrecise Antibodies, ImmunoQure, ImmunoScape, Immunscape, Immunyx Pharma, ImmuPharma, Immusoft, Immutep, ImmVira, ImPact Biotech, IMPACT Therapeutics, Imperial College London, Imugene, IMV, Inceptor Bio, Incyte, Indapta Therapeutics, Indivior, Indivumed, IndyGeneUS AI, Inhibrx, Initium Therapeutics, Inivata, InnDura Therapeutics, InnoCentive, InnoRNA, Innovare, Innovate Biopharmaceuticals, Innovate UK, Innovative Medicines Initiative (IMI), Innovent Biologics, Inotrem, Inovio, Inovio Pharmaceuticals, Insilico Biotechnology, Insilico Medicine, InSilicoTrials, Insitro, Instem, Institut des Biomolécules Max Mousseron, Institute for Research in Immunology and Cancer – Commercialization of Research, Institute of Cancer Research, Institute of Materia Medica, Institute of Molecular and Clinical Ophthalmology Basel, Institute of Neurodegenerative Diseases, Institut Gustave Roussy, Institut Pasteur, InSysBio, INTACT Solutions, Integral Molecular, Integrated BioTherapeutics, Integra Therapeutics, Intellia Therapeutics, INTELLiSTEM, Intensity Therapeutics, Intermountain Healthcare, InterVenn, IntoCell, Intract Pharma, Intravacc, iNtRON Biotechnology, Invasight, InveniAI, Invenra, Inventiva, Inventum Genetics, Invetech, Invetx, InvisiShield Technologies, Invitae, InxMed, Ionis Pharmaceuticals, IONTAS, Iovance Biotherapeutics, iPrime Therapeutics, iProgen Biotech, Ipsen, ISD Immunotech, Isofol Medical, IsoPlexis, Israel Institute for Biological Research, Italian Association for the Study of Pancreas, Iterion Therapeutics, ITM Isotopen Technologien, Itochu, iTolerance, IUCT, Iveric Bio, Jackson Laboratory, Jacobio Pharmaceuticals, Jain Foundation, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Janssen Therapeutics, Janux Therapeutics, Jasper Therapeutics, Javelin Biotech, Jazz Pharmaceuticals, Jenner Institute, Jenthera Therapeutics, JEOL, Jiangsu Alphamab, Jiangsu Chia Tai Tianqing Pharmaceutical, Jiangsu Hansoh Pharmaceutical, Jiangsu Hengrui Medicine, Jiangsu NHWA Pharmaceutical, Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Consumer Companies, Johnson & Johnson Innovation, John Wayne Cancer Institute, Journey Medical, JSR Life Sciences, Jubilant Biosys, Jubilant Radiopharma, Jubilant Therapeutics, Jumpcode Genomics, Junshi Biosciences, Juvenile Diabetes Research Foundation, Kadimastem, KAHR Medical, Kainos Medicines, Kalbe Genexine Biologics, Kaleido Biosciences, KaliVir Immunotherapeutics, Kallyope, Kamada, Kane Biotech, KangaBio, Kantonsspital St. Gallen, Karolinska Institute, Kartos Therapeutics, Karuna Therapeutics, Kazia Therapeutics, KBI BioPharma, KBio, KBP BioSciences, Kedrion Biopharma, Keio Gijuku University, Kelun-Biotech Biopharmaceutical, Kennedy Institute of Rheumatology, Kentucky Organ Donor Affiliates, kENUP Foundation, Khalpey AI Lab, Kiadis Pharma, Kings College London, Kiniksa Pharmaceuticals, Kiromic Biopharma, Kite Pharma, Kiyatec, Kodiak Sciences, Korro Bio, Kronos Bio, Krystal Biotech, KSQ Therapeutics, Kumquat Biosciences, Kura Oncology, Kurma Life Sciences Partners, Kymab, Kymera Therapeutics, Kyn Therapeutics, Kyorin Pharmaceutical, Kytopen, Kyverna Therapeutics, L'Oreal, Labcyte, Laboratoires Thea, Laboratorios Farmaceuticos Rovi, Laboratory Corporation of America, Lacerta Therapeutics, Lactiga, La Jolla Institute for Allergy & Immunology, Landmark Bio, Landos Biopharma, Lantern Pharma, Lantheus Holding, La Paz Hospital, Lassen Therapeutics, Launch Therapeutics, Lava Therapeutics, Lavie Bio, Lawrence Livermore National Laboratory, Leaf Expression Systems, Lee Moffitt Cancer Center, Legend Biotech, LegoChem Biosciences, Leiden University, Leidos, LEO Pharma, Lesaffre, Les Laboratoires Servier, Leukocare, LEXEO Therapeutics, Lexicon Pharmaceuticals, LFB Biotechnologies, LFB Group, LG Chem, LG Life Sciences, LianBio, Libera Bio, LiberoThera, LifeArc, Life Edit Therapeutics, LifeMap Sciences, LIfT BioSciences, Light Chain Bioscience, LimmaTech Biologics, Lineage Cell Therapeutics, Linus Biotechnology, Lion TCR, Little Warrior Foundation, Lixte Biotechnology, Locus Biosciences, LogicBio Therapeutics, Logomix, Long Island University, Lonza, LoQus23 Therapeutics, Loulou Foundation, Loxo Oncology, Lucence, Ludwig Institute for Cancer Research, Luminary Therapeutics, Lumos Pharma, Lunaphore, Lundbeck, Lung Biotechnology, Lupagen, Luxembourg Institute of Health, Luxna Biotech, Lycia Therapeutics, Lyell Immunopharma, LyGenesis, Lyndra Therapeutics, Lysando, Lysogene, Lytix Biopharma, Maastricht University, MAbSilico, Mabylon, Macomics, Macrogen, Macrogenics, Magellan Healthcare, Magenta Therapeutics, MAIA Biotechnology, Mainz Biomed, Mallinckrodt Pharmaceuticals, Mammoth Biosciences, Manhattan BioSolutions, MapKure, Marengo Therapeutics, Marinus Pharmaceuticals, Maruho, Massachusetts General Hospital, Massachusetts Institute of Technology, Massive Bio, Mateon Therapeutics, Matinas Biopharma, Maverick Therapeutics, Mawi DNA Technologies, Max-Planck, Max Biopharma, Mayo Clinic, McKesson, McMaster University, McQuade Center for Strategic Research and Development, mCureX Therapeutics, MD Anderson Cancer Center, MDimune, Medac, Medicago, Medical University of Graz, Medical University of Vienna, Medichem International, MediciNova, MEDiC Life Sciences, MediGene, Medigen Vaccine Biologics, Medimabs, MedImmune, MED Institute, Medipal Holdings, MediSix Therapeutics, Medivir, Medivizor, MedPacto, MeiraGTx, Mekonos, Memorial Sloan Kettering Cancer Center, Memo Therapeutics, Menarini, MercachemSyncom, Merck and Co, Merck KGaA, Merck Sharpe & Dohme, Mereo BioPharma, Meridian Bioscience, Mersana Therapeutics, Merus, Mesoblast, Mestag Therapeutics, Metabolon, Metagenomi, Metrion Biosciences, Michael J Fox Foundation, Microba Life Sciences, MicroBiome Therapeutics, Microbiome Therapeutics Innovation Group, Microbiotica, MicroMGx, Microsoft, MiMedx, Mimetas, MiNA Therapeutics, Minovia Therapeutics, Mirati Therapeutics, miRecule, Mirimus, Miromatrix Medical, Mirus Bio, Mission Bio, MitoSense, Mitsubishi Tanabe Pharma, Moderna, ModeX Therapeutics, Molcure, Molecular Assemblies, Molecular Health, Molecular Partners, Moleculera Labs, Monopar Therapeutics, Morgenesis, Morningside Ventures, Morphic Therapeutic, MorphoSys, Mor Research Applications, Mosaic Biosciences, Moss Genomics, Mount Sinai Health System, MRM Health, MSD, MTF Biologics, Multimmune, Multiple Myeloma Research Foundation, Murdoch Childrens Research Institute, MyBiotics Pharma, My Care Express Merrillville, Myeloid Therapeutics, Myeloproliferative Neoplasm Research Consortium, MYND Life Sciences, myNEO, MyoKardia, Myotonic Dystrophy Clinical Research Network, Myovant Sciences, My Personal Therapeutics, Myriad Genetics, Mythic Therapeutics, myTomorrows, n-Lorem Foundation, Namocell, Nanjing Leads Biolabs, Nanobiotix, Nanocarry Therapeutics, NanoCellect Biomedica, NanoMab Technology, NanoString Technologies, NantKwest, NapaJen Pharma, NASA, Nascent Biotech, Nashville Biosciences, Natera, National Academy of Medicine, National Cancer Center, National Cancer Center of Japan, National Cancer Institute, National Center for Advancing Translational Sciences (NCATS), National Cerebral and Cardiovascular Disease Research Center, National Comprehensive Cancer Network (NCCN), National Heart, Lung and Blood Institute, National Human Genome Research Institute, National Institute for Bioprocessing Research and Training, National Institute for Health Research (NIHR), National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Food and Agriculture, National Institute of Infectious Diseases, National Institute of Neurological Disorders and Stroke, National Institute on Drug Abuse (NIDA), National Institutes of Health, National Research Council Canada, National Research Council of Canada, National Resilience, National University of Singapore, Nationwide Children’s Hospital, Natural Sciences and  Engineering Research Council of Canada, NatureWorks, Nautilus Biotech, Navigo Proteins, Navrogen, NBE Therapeutics, Ncardia, Nebraska Medicine, NEC, Nektar Therapeutics, Neochromosome, NeoCura Bio-Medical Technology, Neogap Therapeutics, Neogene Therapeutics, Neogenomics, Neotope, NeoX Biotech, Netherlands Cancer Institute, NeuCyte, NeuExcell, Neukio Biotherapeutics, Neumora Therapeutics, Neuramedy, Neurimmune Therapeutics, Neurix, Neurochase, Neurocrine Biosciences, Neurogene, NeuroLucent, Neuronetrix, Neurophth Therapeutics, NeuroSense Therapeutics, New England Biolabs, New Jersey Urology, Newomics, Newsoara Biopharma, NewStem, New York Blood Center, New York Presbyterian/Columbia, Neximmune, NextChem, NextCure, NEXT Oncology, Nimble Therapeutics, NIMIUM Therapeutics, NIMML Institute, NImmune Biopharma, Nippon Shinyaku, NJ Bio, Nkarta Therapeutics, NKGen Biotech, NKMax America, Noga Therapeutics, Noile-Immune Biotech, Nona Biosciences, NonExomics, Nordic Bioscience, Normunity, North Carolina State University, Northeastern University, Northern Biologics, North Med, NorthStar Medical Radioisotopes, Notch Therapeutics, Novartis, Novasep, Novavax, Novellus Biopharma, Novigenix, NovoCodex, Novome Biotechnologies, Novo Nordisk, Novoron Bioscience, Novozymes, Nrgene, Nucleai, Numab, NuProbe, Nurix Therapeutics, Nutricion, Nvidia, Nykode Therapeutics, NYU Langone Medical Center, Oblique Therapeutics, Obsidian Therapeutics, Octapharma, Ocular Therapeutics, Ocular Therapeutix, Odylia Therapeutics, Ohio State University, Olink Bioscience, OliX Pharmaceuticals, Omeros, Omico, OmniaBio, OncoArendi Therapeutics, OncoC4, OncoCyte, Oncode Institute, Oncodesign, OncoDNA, Oncoheroes Biosciences, OncoHost, OncoImmunity, Oncologie, Oncolytics Biotech, OncoMyx Therapeutics, OncoNano Medicine, Onconova Therapeutics, Oncora Medical, Oncorus, OncoSec Medical, Oncoshot, Oncosyne, Oncternal Therapeutics, OneOncology, OneThree Biotech, oNKo-innate, ONK Therapeutics, Ono Pharmaceutical, Onramp Bioinformatics, Ontada, OpenBench, OpGen, Opsis Therapeutics, OptraHEALTH, Oragenics, Orange Grove Bio, Orano Med, Orbit Discovery, Orchard Therapeutics, Ordaos Bio, Oregon Health Sciences University, Orexia Therapeutics, Organo Therapeutics, Organovo, Orgenesis, Ori Biotech, Origenis, OrigiMed, Orion, Orion Genomics, Orionis Biosciences, Orna Therapeutics, Orphazyme, Oryzon, OSE Immunotherapeutics, Osivax, Ossium Health, Otsuka, Ottawa Hospital Research Institute, Outpace Bio, Ovid Therapeutics, Owkin, Oxford Biodynamics, Oxford BioMedica, Oxford BioTherapeutics, Oxford Genetics, Oxford Nanopore Technologies, Oxgene, Oxyrane UK, Oyster Point Pharma, Ozette Technologies, Pacific Biosciences, PACT Pharma, Palleon Pharmaceuticals, Panacea Biotech, panCELLa, Pandion Therapeutics, Pangea Biomed, Pantherna Therapeutics, PAQ Therapeutics, Paragon Genomics, Paraza Pharma, Parexel, Parkinsons Disease Foundation, Parse Biosciences, Partnership for Accelerating Cancer Therapies, Partner Therapeutics, Parvus Therapeutics, Pascal Biosciences, Passage Bio, PathAI, Pathalys Pharma, Pathios Therapeutics, PatientsLikeMe, PaxMedica, PDC*line Pharma, PDS Biotechnology, Penn State Cancer Institute, Pennsylvania Biotechnology Center, Pepscan, PeptiDream, Peptilogics, Peptone, Perelman School of Medicine, Persephone Biosciences, Personal Genome Diagnostics, Personalis, Peter Doherty Institute for Infection and Immunity, Pfizer, PGI Drug Discovery, Phanes Therapeutics, PharmAbcine, PharmaEssentia, PharmaJet, Pharming Group, Phase Genomics, PhenoVista Biosciences, Pherecydes Pharma, Philogen, Phio Pharmaceuticals, Phlox Therapeutics, PhoreMost, PhotonPharma, pH Pharma, Pieris Pharmaceuticals, Pierre Fabre, Pillar Biosciences, Pionyr Immunotherapeutics, PlantArcBio, Plastomics, Plexium, Plex Research, Pluristem Therapeutics, Pluristyx, PolarisQB, PoloMar Health, PolyPeptide Group, Poseida Therapeutics, PostEra, PPD, Praxis Precision Medicines, Precision BioSciences, Predictive Oncology, Prellis Biologics, Presage Biosciences, Pressure BioSciences, Prevail Therapeutics, Prime Medicine, Primordial Genetics, PRISM BioLab, ProBioGen, Progenetics, Promethera Biosciences, Prometheus Biosciences, Pro Pharmaceuticals, Prophase Labs, ProQinase, ProQR Therapeutics, Prostate Cancer Clinical Trials Consortium, Proteic Bioscience, ProteinQure, ProteinTech, Proteona, Proteovant Therapeutics, Prothena, Providence Cancer Institute, Providence Saint John's Health Center, Providence Therapeutics, PROVIREX Genome Editing Therapies, Proxygen, Psilera, PsychoGenics, PTC Therapeutics, Pulmonary Fibrosis Foundation (PFF), Puma Biotechnology, Purdue Pharma, Pure Biologics, PureTech Health, Purple Biotech, Q-Gen Cell Therapeutics, Q-State Biosciences, Q2 Solutions, Q32 Bio, Q BioMed, QED Therapeutics, Qiagen, Qilu Pharmaceutical, Qpex Biopharma, Qualigen, Quantgene, Quantoom Biosciences, QuantumDx, Quantum Leap Health Care Collaborative, Qu Biologics, Queen Mary University of London, Queensland Institute of Medical Research (QIMR), Quell Therapeutics, Quibim, QurAlis, R4D Biotech, Race Oncology, Radboud University Nijmegen, Rady Children's Institute for Genomic Medicine, Ragon Institute, Rakuten Medical, Rallybio, RAPT Therapeutics, RARE-X, Rarebase, Rare Disease Company Coalition, RayzeBio, Realm IDx, Rebiotix, Reckitt Benckiser, ReCode Therapeutics, Recombia Biosciences, Recombinetics, Recursion, Redbiotec, RedHill Biopharma, Refana, Refuge Biotechnologies, Rega Institute for Medical Research, Regeneron Genetics Center, Regeneron Pharmaceuticals, RegenLab, Regenxbio, Reglagene, Regulus Therapeutics, ReiThera, Relay Therapeutics, Relief Therapeutics, REMD Biotherapeutics, Remix Therapeutics, RenovoRx, Rentschler Biotechnologie, Repertoire Genesis, Repertoire Immune Medicines, Replicate Bioscience, Replicel Life Sciences, ReproCell, Resilience, Resolution Therapeutics, Resonant Therapeutics, resTORbio, Retrogenix, reViral, ReviR Therapeutics, Revitope Oncology, Revive Therapeutics, RevolKa, Revolution Medicines, Revvity, Rexahn Pharmaceuticals, Reyon Pharmaceuticals, Rezolute, Rheos Medicines, Ribometrix, Ridgeback Biotherapeutics, RIKEN Center for Integrative Medical Sciences, RIKEN Research Institute, RNAGene, Robotic Biology Institute, Roche, Roche Diagnostics, Rocket Pharmaceuticals, Roivant Sciences, RoosterBio, Rosetta Biosciences, Royal Children’s Hospital, Royaltech Med, RQ Biotechnology, Rubedo Life Sciences, RubrYc Therapeutics, Rutgers Cancer Institute of New Jersey, RxCell, Ryvu Therapeutics, S2 Genomics, SAB Biotherapeutics, Sage Therapeutics, Sairopa, Saladax Biomedical, Salarius Pharmaceuticals, Salipro Biotech, Salk Institute, Salveo Diagnostics, Samsung Biologics, Samyang Biopharmaceuticals, Sandoz, SanegeneBio, Sangamo Therapeutics, Sanofi, Sanofi-Pasteur, Sano Genetics, Sanquin Blood Supply Foundation, Santen Pharmaceutical, Sanyou Biopharmaceuticals, Saol Therapeutics, Saphetor, Sapien Biosciences, Sapience Therapeutics, SaponiQx, Sarah Cannon Research Institute, Sarepta Therapeutics, Sartorius, Sartorius Stedim Biotech, Satio, ScaleReady, Scandinavian Biopharma, Scandion Oncology, Scenic Biotech, Scholar Rock, Schrodinger, Science for Life Laboratory, SciNeuro Pharmaceuticals, Scipher Medicine, Scorpion Therapeutics, Scribe Therapeutics, Scripps Research Institute, Scriptr Global, SCTbio, Seagen, Sean M Healey & AMG Center for ALS, Seattle Childrens Research Institute, Seattle Genetics, Secarna Pharmaceuticals, Second Genome, Sedec Therapeutics, Seelos Therapeutics, Selagine, Selecta Biosciences, Selexis, Selvita, Sema4, SemaThera, Sengenics, SEngine Precision Medicine, Sensei Biotherapeutics, Sensorion, Sentia Medical Sciences, Senti Biosciences, Sentinel Oncology, Seqirus, Sequence Bio, SequMed, Seres Therapeutics, Sernova, Serotiny, Serum Institute of India, Seven and Eight Biopharmaceuticals, Sexton Biotechnologies, Shanghai Affinity Biopharmaceutical, Shanghai Pharmaceuticals Holdings, Shanghai ZhenGe Biotechnology, Shape Therapeutics, Shasqi, Sheba Medical Center, Shenogen Pharma, Shenzhen Chipscreen Biosciences, Shepherd Therapeutics, Sherlock Biosciences, Shimadzu, Shineco, Shinshu University, Shionogi, Shoreline Biosciences, Sidney Kimmel Cancer Center, Siemens Healthineers, Sigilon Therapeutics, SilcsBio, Silence Therapeutics, Simnova, Simons Searchlight, Simsen Diagnostics, Singapore Eye Research Institute (SERI), Singleron Biotechnologies, Singular Genomics Systems, Sino Biopharmaceutical, SinoMab Bioscience, Sinorda Biomedicine, Sinovac Biotech, Siolta Therapeutics, Sirion Biotech, Sirnaomics, Sironax, SIRS Therapeutics, SiSaf, Siteman Cancer Center, Sitryx, SK Biopharmaceuticals, SK Bioscience, SK Chemicals, Skyhawk Therapeutics, SkylineDX, Skyline Therapeutics, Sleep Consortium, Smart Immune, SmartPharm Therapeutics, Sofie Biosciences, Solarvest BioEnergy, Solasia Pharma, Soleno Therapeutics, Solentim, Solid Biosciences, SomaLogic, SOM Biotech, Sonnet BioTherapeutics, Sonoma BioTherapeutics, SonoThera, SOPHiA Genetics, Sorrento Therapeutics, Sorse Technology, Sosei, Sosei Heptares, SOTIO, Spanish National Research Council, SparingVision, Spark Therapeutics, Specifica, Sphere Fluidics, SpringWorks Therapeutics, Sprint Biosciences, SQZ Biotech, STADA Arzneimittel, Standigm, Stanford University, Stanford University School of Medicine, State of Victoria, Statera Biopharma, Stealth BioTherapeutics, Steinbeis Centre for Biopolymer Analysis and Biomedical Mass Spectrometry, Stem Genomics, StemoniX, Stoke Therapeutics, Storm Therapeutics, StrideBio, Sumitomo Chemical Company, Sumitomo Dainippon Pharma, Sumitovant Biopharma, Summit Therapeutics, Sun Genomics, Sun Pharma Advanced Research Company, SunRock Biopharma, Sunshine Biopharma, Surrozen, Suzhou Porton Advanced Solutions, Swiss Integrative Center for Human Health, Syapse, Sygnature Discovery, Symvivo, Synaffix, Syndax Pharmaceuticals, Syneos Health, Synexa Life Sciences, Syngene International, Synlogic, Syntegra, Synthego, SyntheX, T-MAXIMUM Biotech, Takara Bio, Takeda Pharmaceutical, Takis Biotech, Talaris Therapeutics, Talem Therapeutics, Talix Therapeutics, Tallac Therapeutics, Tampa General Hospital Cancer Institute, Tampere University Hospital, TARA Biosystems, Targovax, Taros Chemicals, Tauriga Sciences, Tavotek Biotherapeutics, Tavros Therapeutics, Taysha Gene Therapies, TB Alliance, TC BioPharm, TCR2 Therapeutics, Tegmine Therapeutics, Teijin, Tel Aviv Sourasky Medical Center, Telesis Bio, Tella, Tempus, TeneoBio, TenNor Therapeutics, Tentarix Biotherapeutics, Terray Therapeutics, Terumo Blood and Cell Technologies, TeselaGen, Tesis Biosciences, Tessa Therapeutics, Tessera Therapeutics, Tetragenetics, Tevard Biosciences, Texas Lung Injury Institute, Texcell, TFF Pharmaceuticals, TGen Drug Development, TG Therapeutics, The International AIDS Vaccine Initiative, The Medical Research, Infrastructure, and Health Services Fund of the Tel Aviv Medical Center, Themis Bioscience, The Native Antigen Company, The Parker Institute For Cancer Immunotherapy, Theracell, Theragen, TheraPanacea, Thermo Fisher Scientific, The Silverstein Foundation for Parkinson's, ThinkCyte, Thomas Jefferson University, Tianjin CanSino Biotechnology, Tianjin University, Tiba Biotech, TILT Biotherapeutics, TiumBio, T Med, TMG - Tropical Melhoramento e Genética, Tmunity Therapeutics, Today TCI, Tolo Biotech, TOMI Environmental Solutions, Toolgen, Top Seeds International, Toronto Innovation Acceleration Partners, Touchlight, TRACON Pharmaceuticals, Trakcel, TransCelerate BioPharma, Transgene, Transimmune, Translate Bio, Translational Genomics Research Institute, TransThera, TreeFrog Therapeutics, Treehill Partners, Trevena, Treventis, TRexBio, TrialSpark, Trianni, Trigone Pharma, TriLink BioTechnologies, Triphase Accelerator, Triumvira Immunologics, TrovaGene, Trutino Biosciences, TSB Therapeutics, TScan Therapeutics, Tubulis, TumorGen, Turnstone Biologics, Twinstrand Therapeutics, Twist Bioscience, twoXAR, U-Diagnostics, uBiome, UbiVac, Ubix Therapeutics, UCB, UK Government, Ultima Genomics, Ultivue, Ultragenyx Pharmaceuticals, Umoja Biopharma, Unilever, UNION Therapeutics, UniQure, United Immunity, United Therapeutics, Univercells, University College London, University Gottingen, University Health Network, University Medical Center Groningen, University of Alabama at Birmingham, University of Antwerp, University of Arizona, University of British Columbia, University of California, Davis, University of California Berkeley, University of California Irvine, University of California Riverside, University of California San Francisco, University of Cambridge, University of Chicago, University of Colorado, University of Dundee, University of Edinburgh, University of Florida, University of Georgia, University of Heidelberg, University of Kiel, University of Lausanne, University of Leipzig, University of Leuven, University of Liverpool, University of Louisville, University of L’Aquila, University of Manchester, University of Marburg, University of Maryland, University of Maryland School of Medicine, University of Massachusetts Medical School, University of Melbourne, University of Miami, University of Michigan, University of Minnesota, University of Montreal, University of Newcastle, University of North Carolina, University of Oxford, University of Pennsylvania, University of Pittsburgh, University of Queensland, University of Saskatchewan, University of Surrey, University of Texas, University of Texas Health Science Center at Tyler, University of Texas Medical Branch, University of Texas Southwestern Medical Center, University of the Witwatersrand, University of Toronto, University of Verona, University of Washington, University of Wisconsin, University of Wollongong, University of Zurich, Unlearn, UPL, UPMC, Uppsala University, Urovant Sciences, US Army Medical Research and Material Command, US Department of Agriculture, US Government, US Oncology, US Oncology Research, Utrecht University, Vaccibody, Vaccitech, Valent Biosciences, Valitacell, Vall d’Hebron Research Institute, Valneva, Valo Therapeutics, Van Andel Institute, Vanderbilt University, VaxAlta, Vaxart, VaxEquity, Vaxess Technologies, Vaxil BioTherapeutics, VaxThera, Vaxxinity, VBI Vaccines, VeCollal, Vect-Horus, VectorY Therapeutics, Veeva Systems, Velabs Therapeutics, Veracyte, Verantos, Verge Genomics, Verily, Veritas, Verne Global, Verseau Therapeutics, Vertex Pharmaceuticals, Verve Therapeutics, VGI Health Technology, VIB, Victoria University, VieCure, Viela Bio, Viewpoint Molecular Targeting, ViGeneron, ViiV Healthcare, Vinbiocare Biotechnology, Vincere Biosciences, Vineti, Viome, Vipergen, Vir Biotechnology, Virginia Commonwealth University, Virica Biotech, Viroclinics Biosciences, Virogen, VisualDx, Viva Biotech, Vivante Health, VIVEbiotech, Vivet Therapeutics, Vividion Therapeutics, Vivlion, Vivoryon Therapeutics, Volastra Therapeutics, VolitionRX, Volpara Solutions, Vor Biopharma, Voyager Therapeutics, Vrije Universiteit Brussel, Vuja De Sciences, Vyant Bio, Vycellix, Vyriad, Wageningen University, Wake Forest Institute for Regenerative Medicine, Washington University in St Louis, Watchmaker Genomics, WaVe Lifesciences, Weill Cornell Medical College, Weizmann Institute, Werewolf Therapeutics, Western Digital, WhiteLab Genomics, WIN Consortium, WindMIL Therapeutics, WinterLight Labs, Wisconsin Alumni Research Foundation, Wistar Institute, W L Gore, Wonkwang University, WUGEN, WuXi Biologics, Wuxi Shuangliang Biotechnology, Wuxi STA, WuXi XDC, Wyss Institute, X-chem, Xbiome, Xcell Biosciences, xCures, Xencor, Xenetic Biosciences, Xenon Pharmaceuticals, XERIS Pharmaceuticals, Xilio Therapeutics, Xilis, Xlife Sciences, XNK Therapeutics, XtalPi, Xylyx Bio, Xyphos Biosciences, Y-Biologics, Yale Cancer Center, Yale University, Yemaachi Biotech, Yissum Research Development, Ymmunobio, Yonsei University Severance Hospital, Yufan Biotechnologies, YUMAB, ZAI Laboratory, Zealand Pharma, ZebiAI Therapeutics, ZeClinics, Zelluna Immunotherapy, Zentalis Pharmaceuticals, Zenyaku Kogyo, Zephyr AI, Zevra Therapeutics, Ziphius Vaccines, Zoetis, Zogenix, Zymedi, Zymergen, ZYUS Life Sciences, ZyVersa Therapeutics

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.

We found other products you might like!